<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: We tested the hypothesis that the administration of the competitive <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi> (<z:chebi fb="0" ids="31882">NMDA</z:chebi>) receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> 2R,4R,5S-(2-amino-4,5-(1,2-<z:chebi fb="0" ids="52552">cyclohexyl</z:chebi>)-7-phosphonoheptanoic acid) (NPC 17742) or cis-4-(phosphonomethyl) <z:chebi fb="0" ids="17964">piperidine-2-carboxylic acid</z:chebi> (CGS 19755) or the noncompetitive <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> dizocilpine (MK-801), at the appropriate doses, would <z:hpo ids='HP_0000001'>all</z:hpo> have efficacy in decreasing early postischemic brain injury in a feline model of transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN: Prospective, randomized, controlled animal trial </plain></SENT>
<SENT sid="2" pm="."><plain>SETTING: University research laboratory </plain></SENT>
<SENT sid="3" pm="."><plain>SUBJECTS: Forty mixed-breed cats </plain></SENT>
<SENT sid="4" pm="."><plain>INTERVENTIONS: <z:chebi fb="2" ids="5615">Halothane</z:chebi>-anesthetized cats underwent 90 mins of left middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> plus 4 hrs of reperfusion </plain></SENT>
<SENT sid="5" pm="."><plain>At 75 mins of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, control cats received intravenous saline (n = 10) </plain></SENT>
<SENT sid="6" pm="."><plain>Experimental cats (n = 10 in each group) were treated with NPC 17742 (5 mg/kg bolus and 2.5 mg/kg/hr throughout reperfusion), MK-801 (5 mg/kg intravenous bolus), or CGS 19755 (40 mg/kg intravenous bolus) in a randomized fashion </plain></SENT>
<SENT sid="7" pm="."><plain>MEASUREMENTS AND MAIN RESULTS: Microsphere-determined blood flow to the ipsilateral inferior temporal cortex and caudate nucleus decreased to the same extent during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, and recovered to the same extent during early reperfusion, in the four groups </plain></SENT>
<SENT sid="8" pm="."><plain>Triphenyltetrazolium-determined injury volume of the ipsilateral caudate nucleus in cats treated with NPC 17742 (105 +/- 25 [<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e>] mm3), MK-801 (97 +/- 22 mm3), and CGS 19755 (97 +/- 13 mm3) was less than in control cats (198 +/- 21 mm3) </plain></SENT>
<SENT sid="9" pm="."><plain>Hemisphere injury volumes with NPC 17742 (1209 +/- 405 mm3) and MK-801 (1338 +/- 395 mm3) were less than that value in controls (2193 +/- 372 mm3), whereas injury volume with CGS 19755 (1553 +/- 519 mm3) treatment did not attain significance (p &lt; .09) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptor activation during reperfusion may contribute to the progression of injury in ischemic border regions after 90 mins of transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in the cat </plain></SENT>
<SENT sid="11" pm="."><plain>At the doses chosen, there appear to be no major differences in therapeutic efficacy for competitive and noncompetitive <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptor <z:chebi fb="68" ids="48706">antagonists</z:chebi> </plain></SENT>
</text></document>